March 19, 2015
SEATTLE, March 19, 2015 – TapImmune Inc. (OTCBB: TPIV) is pleased to announce the appointment of David Laskow-Pooley to the Company’s Board of Directors.
David brings 30 years of experience in all aspects of the discovery, development and commercialization of pharmaceutical and healthcare products.
March 10, 2015
Investment bolsters immediate capital needs for progressing clinical programs
SEATTLE, March 10, 2015 – TapImmune, Inc. (OTCQB: TPIV), is pleased to announce a US$1 million investment from Eastern Capital Limited under the same terms as the recent January 12, 2015 round of financing.